NDAORALTABLET, CHEWABLE
Approved
Nov 1996
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Data completeness
4/8 — Partial
CHILDREN'S MOTRIN (ibuprofen) by Design Pharmaceuticals is cyclooxygenase inhibitors [moa]. Approved for pain, fever, juvenile idiopathic arthritis and 1 more indications. First approved in 1996.
Drug data last refreshed 21h ago
Mechanism of Action
Cyclooxygenase Inhibitors
Indications (4)
Worked on CHILDREN'S MOTRIN at Design Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.